|
OTLK Outlook Therapeutics Inc 1649989 |
| Balance Sheet |
|
Current Assets
|
$20,904,711.00 |
|
Assets
|
$21,892,406.00 |
|
Current Liabilities
|
$38,883,990.00 |
|
Liabilities
|
$50,887,177.00 |
|
Equity
|
$-28,994,771.00 |
|
Shares Out
|
104614219.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-22,767,166.00 |
| Market Analysis |
Market Cap
|
$108,798,787.76 |
|
Price
|
$0.95 |
|
PB
|
0.15 |
|
EPS
|
-0.05 |
|
PS
|
107.31 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-17 |
-0.22 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-15 |
-0.16 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OTLK documents filed with the SEC.
OTLK Filings
Clear
